New Light-Based scanner could spot cancer without needles

NCT ID NCT05488483

Ongoing Diagnosis Sponsor: Memorial Sloan Kettering Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests whether a new imaging technique called multispectral optoacoustic tomography (MSOT) can visualize breast cancer and melanoma tumors. Twelve participants will have MSOT scans before their standard biopsy or treatment. The goal is to see if MSOT can detect tumors and measure oxygen levels, which might help improve cancer diagnosis in the future.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Multispectral Optoacoustic Tomography (MSOT) imaging
What this could lead to: If successful, this could lead to a new, non-invasive way to detect and monitor tumors without radiation or contrast dyes.
What could go wrong: This is a very small feasibility study with only 12 participants, so results may not apply to everyone. The technology is still experimental and may not work as hoped.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm melanoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER MELANOMA

Contacts and locations

Locations

Helmholtz Institute (Data Analysis Only)

Munich, Germany
Memorial Sloan - Kettering Cancer Center

New York, New York, 10021, United States
Memorial Sloan Kettering Bergen (Consent only )

Montvale, New Jersey, 07645, United States
Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Consent only)

Commack, New York, 11725, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.